Exploring the mode of action of ebselen in Trypanosoma brucei hexokinase inhibition

International Journal for Parasitology: Drugs and Drug Resistance

Volumn 3, Issue , 2013, Pages 154-160

  Joice, April C ^a,c   Harris, Michael T ^a   Kahney, Elizabeth W ^a   Dodson, Heidi C ^a,d   Maselli, Andrew G ^b   Whitehead, Daniel C ^a   Morris, James C ^a  

^a CLEMSON UNIVERSITY   (United States)

^b CHICAGO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d North Greenville University   (United States)

Author keywords

Ebselen; Hexokinase; Inhibitors; Trypanosoma brucei

Indexed keywords

EBSELEN; HEXOKINASE 1; OLIGOMER;

ARTICLE; CATALYSIS; ELECTRON MICROSCOPY; ENZYME INACTIVATION; ENZYME INHIBITION; MASS SPECTROMETRY; NONHUMAN; OLIGOMERIZATION; OXIDATION; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; TRYPANOSOMA BRUCEI;

EID: 84884574803     PISSN: 22113207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpddr.2013.08.002     Document Type: Article

References (19)

1. Bayer E.A., Zalis M.G., Wilchek M. 3-(N-Maleimido-propionyl)biocytin: a versatile thiol-specific biotinylating reagent. Anal. Biochem. 1985, 149:529-536.
2. Borges V.C., Rocha J.B., Nogueira C.W. Effect of diphenyl diselenide, diphenyl ditelluride and ebselen on cerebral Na(+), K(+)-ATPase activity in rats. Toxicology 2005, 215:191-197.
3. Brun R., Blum J., Chappuis F., Burri C. Human African trypanosomiasis. Lancet 2010, 375:148-159.
4. Chambers J.W., Fowler M.L., Morris M.T., Morris J.C. The anti-trypanosomal agent lonidamine inhibits Trypanosoma brucei hexokinase 1. Mol. Biochem. Parasitol. 2008, 158:202-207.
5. Chambers J.W., Kearns M.T., Morris M.T., Morris J.C. Assembly of heterohexameric trypanosome hexokinases reveals that hexokinase 2 is a regulable enzyme. J. Biol. Chem. 2008, 283:14963-14970.
6. Chambers J.W., Morris M.T., Smith K.S., Morris J.C. Residues in an ATP binding domain influence sugar binding in a trypanosome hexokinase. Biochem. Biophys. Res. Commun. 2008, 365:420-425.
7. Dodson H.C., Lyda T.A., Chambers J.W., Morris M.T., Christensen K.A., Morris J.C. Quercetin, a fluorescent bioflavanoid, inhibits Trypanosoma brucei hexokinase 1. Exp. Parasitol. 2010, 127:423-428.
8. Harris M.T., Walker D.M., Drew M.E., Mitchell W.G., Dao K., Schroeder C.E., Flaherty D.P., Weiner W.S., Golden J.E., Morris J.C. Interrogating a hexokinase-selected small molecule library for inhibitors of Plasmodium falciparum hexokinase. Antimicrob. Agents Chemother. 2013, 57:3717-3731.
9. Lu J., Vlamis-Gardikas A., Kandasamy K., Zhao R., Gustafsson T.N., Engstrand L., Hoffner S., Engman L., Holmgren A. Inhibition of bacterial thioredoxin reductase: an antibiotic mechanism targeting bacteria lacking glutathione. FASEB J. 2013, 27:1394-1403.
10. Lu, J., Vodnala, S.K., Gustavsson, A.L., Gustafsson, T.N., Sjoberg, B., Johansson, H.A., Kumar, S., Tjernberg, A., Engman, L., Rottenberg, M.E., Holmgren, A., in press. Ebsulfur is a benzisothiazolone cytocidal inhibitor targeting the trypanothione reductase of Trypanosoma brucei. J. Biol. Chem. http://dx.doi.org/jbc.M113.495101.
11. Misset O., Opperdoes F.R. Simultaneous purification of hexokinase, class-I fructose-bisphosphate aldolase, triosephosphate isomerase and phosphoglycerate kinase from Trypanosoma brucei. Eur. J. Biochem. 1984, 144:475-483.
12. Misset O., Bos O.J., Opperdoes F.R. Glycolytic enzymes of Trypanosoma brucei. Simultaneous purification, intraglycosomal concentrations and physical properties. Eur. J. Biochem. 1986, 157:441-453.
13. Morris M.T., DeBruin C., Yang Z., Chambers J.W., Smith K.S., Morris J.C. Activity of a second Trypanosoma brucei hexokinase is controlled by an 18-amino-acid C-terminal tail. Eukaryot. Cell 2006, 5:2014-2023.
14. Sakurai T., Kanayama M., Shibata T., Itoh K., Kobayashi A., Yamamoto M., Uchida K. Ebselen, a seleno-organic antioxidant, as an electrophile. Chem. Res. Toxicol. 2006, 19:1196-1204.
15. Schewe T. Molecular actions of ebselen - an antiinflammatory antioxidant. Gen. Pharmacol. 1995, 26:1153-1169.
16. Sharlow, E., Golden, J.E., Dodson, H., Morris, M., Hesser, M., Lyda, T., Leimgruber, S., Schroeder, C.E., Flaherty, D.P., Weiner, W.S., Simpson, D., Lazo, J.S., Aube, J., Morris, J.C., 2010a. Identification of Inhibitors of Trypanosoma brucei Hexokinases, Probe Reports from the NIH Molecular Libraries Program, Bethesda (MD).
17. Sharlow E.R., Lyda T.A., Dodson H.C., Mustata G., Morris M.T., Leimgruber S.S., Lee K.H., Kashiwada Y., Close D., Lazo J.S., Morris J.C. A target-based high throughput screen yields Trypanosoma brucei hexokinase small molecule inhibitors with antiparasitic activity. PLoS Negl. Trop. Dis. 2010, 4:e659.
18. Terentis A.C., Freewan M., Sempertegui Plaza T.S., Raftery M.J., Stocker R., Thomas S.R. The selenazal drug ebselen potently inhibits indoleamine 2,3-dioxygenase by targeting enzyme cysteine residues. Biochemistry 2010, 49:591-600.
19. Yamaguchi T., Sano K., Takakura K., Saito I., Shinohara Y., Asano T., Yasuhara H. Ebselen in acute ischemic stroke: a placebo-controlled, double-blind clinical trial. Ebselen Study Group. Stroke 1998, 29:12-17.